Concepedia

Peter T. Meinke

PT

Statistics

Publications

97

Citations

5.3K

H-Index

39

Active since

1985

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Tri-Institutional Therapeutics Discovery Institute

Cornell University

United States Military Academy

Weill Cornell Medicine

Peter T. Meinke is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1985–2024

97

Publications

97

Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase

Sandra J. Darkin‐Rattray, Anne Gurnett, Robert W. Myers et al. · Proceedings of the National Academy of Sciences · 1996 · 572 citations · Full text

, , +17

Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression

Lodoe Lama, Carolina Adura, Wei Xie et al. · Nature Communications · 2019 · 283 citations · Full text

, , +17

Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitor

James E. Thompson, Rose M. Cubbon, Richard Cummings et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 270 citations · Full text

, , +12

Guggulsterone Is a Farnesoid X Receptor Antagonist in Coactivator Association Assays but Acts to Enhance Transcription of Bile Salt Export Pump

Jisong Cui, Li Huang, Annie Zhao et al. · Journal of Biological Chemistry · 2003 · 241 citations · Full text

, , +16

Discovery of MK‐8742: An HCV NS5A Inhibitor with Broad Genotype Activity

Craig A. Coburn, Peter T. Meinke, Wei Chang et al. · ChemMedChem · 2013 · 197 citations · Full text

, , +17

1–5 of 97